Draft Scope Consultation
The National Institute for Health and Care Excellence (NICE) has been asked to consider an appraisal of guselkumab for treating active psoriatic arthritis after inadequate response to DMARDs ID1658.
NICE invited organisations to take part in the consultation to discuss the draft remit and scope. The organisations selected as stakeholders are listed here and the draft scope that is being consulted on can be found here.
The consultation closes on Wednesday 18 December 2019. If you have any queries regarding this scoping exercise or would like to be involved you can contact Michelle Adhemar, Scoping Project Manager at scopingta@nice.org.uk…
Read more of this article
by Jenny Brodie, Senior Communications & Brand Officer, NASS
Guest blog by Dr Alison Giles, Associate Director for Healthy Ageing, Centre for Ageing Better and Public Health England; and Elaine Rashbrook, Consultant Specialist, Life Course, Public Health England.
October saw the launch of a new National Academy for Social Prescribing (NASP), to champion social prescribing and the work of local communities in connecting people for wellbeing. Its objectives include exploring new ways of sourcing statutory and non-statutory funding and brokering relationships between different sectors. Given the prevalence of MSK conditions, it is important that social prescribing has something to offer for MSK.
Bone and Joint Week in October helps get people thinking about one of the most widespread and pressing health issues of our times – musculoskeletal health and the role each person in improving it. This year ARMA’s member organisations, Public Health England, NHE England, NHS Confederation and many other organisations collaborated during the campaign using 
ARMA joins Public Health England and the Centre for Ageing Better to make England the best place to grow old, because musculoskeletal health is vital to healthy ageing.
In September, Public Health England published a report on their review of the scale, distribution and causes of prescription drug dependence, and what might be done to address it. This included findings on opioid use for non cancer pain. The report made recommendations for action to reduce the problems caused by dependency and stated that effective, personalised care should include shared decision-making with patients and regular reviews of whether treatment is working.
NASS has just released a new series of videos showing how everyone living with axial spondyloarthritis (axial SpA) – including people with ankylosing spondylitis (AS) – can fit some simple but very effective stretches into their daily life.
NICE are developing 
